Increased interleukin-36 expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sezary syndrome
The Journal of Dermatology Jan 12, 2018
Otobe S, et al. - The intent of the authors was to inspect the role of interleukin-36 (IL-36)γ in atopic dermatitis (AD) and mycosis fungoides (MF)/Sezary syndrome (SS). A rise was noted in the IL-36γ expression in sera and skin of patients with AD and MF/SS, just as in the case of psoriatic patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
